Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02214147
Title Pharmacokinetics of Alisertib in Adults With Advanced Solid Tumors or Relapsed/Refractory Lymphoma With Varying Degrees of Hepatic Function
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Millennium Pharmaceuticals, Inc.
Indications

Advanced Solid Tumor

adult lymphoma

Therapies

Alisertib

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Miami Florida United States Details
Chicago Illinois United States Details
Ann Arbor Michigan United States Details
Saint Louis Missouri United States Details
Dallas Texas United States Details
Houston Texas United States Details
San Antonio Texas United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field